2020
DOI: 10.1038/s41419-020-02805-2
|View full text |Cite
|
Sign up to set email alerts
|

Alpha-lipoic acid protects against pressure overload-induced heart failure via ALDH2-dependent Nrf1-FUNDC1 signaling

Abstract: Alpha-lipoic acid (α-LA), a well-known antioxidant, was proved to active ALDH2 in nitrate tolerance and diabetic animal model. However, the therapeutic advantage of α-LA for heart failure and related signaling pathway have not been explored. This study was designed to examine the role of α-LA–ALDH2 in heart failure injury and mitochondrial damage. ALDH2 knockout (ALDH2−/−) mice and primary neonatal rat cardiomyocytes (NRCMs) were subjected to assessment of myocardial function and mitochondrial autophagy. Our d… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
38
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 48 publications
(39 citation statements)
references
References 47 publications
1
38
0
Order By: Relevance
“…[109], FGF12 [110], AQP4 [111], LMOD2 [112], SELENBP1 [113], MB (myoglobin) [114], S100A1 [115], RYR2 [116], GPC5 [117], JARID2 [118], EGFR (epidermal growth factor receptor) [119], FUNDC1 [120], S1PR1 [121], EPAS1 [122] and OSBPL11 [123] genes are a potential biomarkers for the detection and prognosis of HF at an early age. A previous study reported that CALR (calreticulin) [124], BSCL2 [125], PKD1 [126], TMBIM1 [127], CHST15 [128], NAA10 [129], TCF3 [130], CNN1 [131], TAF1A [132], ACAD9 [133], KLHL24 [134], MYOM2 [135], TRIM63 [136] [210] are the key biomarkers in cardiac hypertrophy.…”
Section: Discussionmentioning
confidence: 99%
“…[109], FGF12 [110], AQP4 [111], LMOD2 [112], SELENBP1 [113], MB (myoglobin) [114], S100A1 [115], RYR2 [116], GPC5 [117], JARID2 [118], EGFR (epidermal growth factor receptor) [119], FUNDC1 [120], S1PR1 [121], EPAS1 [122] and OSBPL11 [123] genes are a potential biomarkers for the detection and prognosis of HF at an early age. A previous study reported that CALR (calreticulin) [124], BSCL2 [125], PKD1 [126], TMBIM1 [127], CHST15 [128], NAA10 [129], TCF3 [130], CNN1 [131], TAF1A [132], ACAD9 [133], KLHL24 [134], MYOM2 [135], TRIM63 [136] [210] are the key biomarkers in cardiac hypertrophy.…”
Section: Discussionmentioning
confidence: 99%
“…The FUNDC1 is a highly conserved mitochondrial outer membrane protein. Similar to BNIP3/NIX, it directly interacts with LC3 through the N end, mediating hypoxia-induced mitophagy, which is widely expressed in various cells, tissues, and organs, particularly heart ( 63 , 79 , 88 , 90 , 92 , 93 ). Under normal oxygen conditions, FUNDC1 phosphorylated by semi refined carrageenan (SRC) kinases and Casein kinase II (CK2) decreases their affinity to LC3, which effectively inhibits mitophagy.…”
Section: The Physiological State Of Mitochondrial Dynamics and Mitophagymentioning
confidence: 99%
“…During hypoxia, it is FUNDC1 dephosphorylated by 13 phosphatases (such as PGAM5) of serine, triggering its binding to LC3 and improving mitophagy activity. It removes damaged mitochondria ( 23 , 79 , 88 , 92 , 93 , 142 144 ). Hypoxia can activate poly (ADP-ribose) polymerase (PARP), promoting mitophagy by regulating mitochondrial membrane potential and inducing cardiomyocyte apoptosis, ROS is central for PARP mediated mitochondrial membrane potential (ΔΨm) decline, and inhibited PARP can reduce the production after injury ( 80 ).…”
Section: The Pathophysiological State Of Mitochondrial Dynamics and Mitophagymentioning
confidence: 99%
See 1 more Smart Citation
“…It has been used as one of the dietary supplements to prevent and treat many diseases, including stroke, diabetes, neurodegenerative and hepatic disorders [13]. In experimental studies, ALA has shown bene cial effects against cardiovascular dysfunction [17], sepsis [18], endothelin dysfunction and oxidative stress [19], testicular dysfunction [20] and liver dysfunction [21]. Recently, ALA has been clinically tested for its bene cial effects in patients with bromyalgia pain [14], multiple sclerosis [22], obesity [23], β-thalassemia [24], diabetes [25], non-alcoholic fatty liver disease [26].…”
Section: Introductionmentioning
confidence: 99%